Global endometrial market value was USD 3.2 billion in 2020. It is projected to grow at a compound annual rate (CAGR), of 5.2% during the forecast period. Due to increasing prevalence of gynecological conditions such as PCOD, menorrhagia and abnormal vaginal bleeding, there is a growing demand for endometrial procedures. According to the CDC, 10,000,000 women in America are affected each year by heavy bleeding (menorrhagia). Technological advancements and the benefits of endometrial ablation over traditional surgical methods are driving this market. Because they offer patients less invasive surgical options to hysterectomy, endometrial ablation is more advantageous.
The advancement of minimally invasive procedures for endometrial ablation has made it possible to remove the endometrium in situ, as a day-care procedure. This procedure is safer and more straightforward. The International Federation of Gynecology and Obstetrics FIGO states that Abnormal Uterine Bleeding in the reproductive years can have a significant global effect with a prevalence of 3 to 30% for reproductive-aged women. This is expected to drive the overall market growth.
All governments and all private organisations around the globe consider women's health a top priority. Women's coverage plans are one of the key elements that will drive the industry in the developed countries. In India, for example, women can claim a number of tax benefits and exemptions under different sections of the income-tax legislation. One of these is the income deduction that can be claimed on premiums for insurance policies. These initiatives may encourage women to adopt the best treatment options, which could boost market growth.
Abnormal uterine bleeding (AUB), is the most common disorder in reproductive-aged women. AUB can cause productivity loss and may require surgical intervention. According to the National Health Portal India AUB can affect between 9 and 14% of women. The prevalence of AUB varies from one country to the next. India has an average frequency of AUB at 17.9%. There are some risks associated with endometrial ablation, including infection and tearing the uterine wall. This could limit market growth.
Due to the COVID-19 pandemic, healthcare has been faced with extraordinary challenges. Because most services were non-urgent, elective and outpatient interventions were stopped or limited during the COVID-19 epidemic to stop the spread of the virus. The lockdown resulted in an increase of elective surgeries by one-fifth. However, COVID-19-related changes to health-care systems increased elective surgery wait times by as much as one-third. The extended wait times could lead to higher mortality rates and more complicated surgeries.
With a more than 70% revenue share, the devices segment led 2020's market. The market can be divided into procedures and devices based on its type. Endometrial Ablation is a method to reduce severe menstrual bleeding. It involves destroying the endometrium (a thin layer of tissue that surrounds the uterus). This segment is growing because of the rising number of women who suffer from menorrhagia. There are many techniques and devices available, including radiofrequency ablation, which uses high-energy radio waves to destroy endometrial tissues; cryoablation where abnormal tissue is frozen and destroyed with an extremely cold liquid or device called a cryoprobe. Balloon therapy, where the fluid is injected into the balloon and the endometrium destroyed.
With a 26.3% revenue share in 2020, radiofrequency ablation was the dominant device segment. It is expected to maintain its dominance over the forecast period. This is due to the product's ease of use, effectiveness, cost-efficiency, and speed of treatment compared with other ablation devices. Radiofrequency ablation devices are also widely available and well-known among doctors. It is expected that the thermal balloon segment will grow at a rapid pace. This is an alternative to hysterectomy and it is less invasive than hysterectomy. It uses a single-use disposable catheter cartridge and has been approved for treatment of menorrhagia by the US Food and Drug Administration.
In 2020, the hospital segment accounted for 55% of the total revenue. This can be attributed to the increase in patients who are hospitalized for gynecological conditions. Hospitals provide excellent care and reimbursements. Hospitals also have advanced treatment equipment, which has contributed to this sector's growth. Hospitals also have a significantly higher number of patients seeking gynecological treatment than other healthcare settings due to their ability to manage any complications that might arise during surgery and the wide variety of treatment options available.
Due to an increase in ASCs, the Ambulatory Surgery Center (ASC), is expected to experience the fastest growth rate over the forecast period. These healthcare settings provide more affordable services, a more convenient environment, and personalized treatment. ASCs are also less likely to experience Hospital-Acquired Infections (HAIs) and have shorter stays. These factors will all contribute to the increasing demand for these facilities.
North America was the dominant market, accounting for 33.6% of the total revenue in 2020. Market growth is expected to be driven by rising gynecological conditions, improved healthcare infrastructure, and the strong foundation of industry leaders to deliver cutting-edge Endometrial Ablation Devices. Patient safety and outcomes are important in the United States. Various projects have been initiated to improve healthcare quality and reduce costs. Another factor that contributes to market growth is the higher healthcare spending in North America than in any other region.
The market in Asia Pacific is expected to experience significant growth over the forecast period. The COVID-19 epidemic has brought to light the regional's shortcomings and flaws in its health system, as well the interdependence between economic stability and health security. The region is now moving closer to achieving Universal Health Care (or UHC). The market will continue to grow due to the increase in menorrhagia rates and the demand for new technology.
The market is highly competitive, with a large number of local and global manufacturers. Major companies have a variety of growth strategies to gain a substantial share of this market. These include new product development, product differentiation, financing, and international strategy. CooperSurgical purchased AEGEA Medical's MaraTM Water Vapor Ablation System in February 2021. These are some of the key players in the global market for endometrial ablation:
Medtronic
CooperSurgical Inc.
Boston Scientific Corp.
Ethicon, Inc. Johnson & Johnson
Olympus Corp.
Richard Wolf GmbH
AngioDynamics
Hologic, Inc.
Minerva Surgical, Inc.
Up Market Research published a new report titled “Endometrial Ablation Market research report which is segmented by Type (Procedures, Devices), by End Use (Hospital, ASC), By Players/Companies Inc; Minerva Surgical, Medtronic; CooperSurgical Inc; Boston Scientific Corporation; Ethicon, Inc (Johnson & Johnson); Olympus Corporation; Richard Wolf GmbH; AngioDynamics; Hologic, Inc”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.
Report Attributes | Report Details |
Report Title | Endometrial Ablation Market Research Report |
By Type | Procedures, Devices |
By End Use | Hospital, ASC |
By Companies | Inc; Minerva Surgical, Medtronic; CooperSurgical Inc; Boston Scientific Corporation; Ethicon, Inc (Johnson & Johnson); Olympus Corporation; Richard Wolf GmbH; AngioDynamics; Hologic, Inc |
Regions Covered | North America, Europe, APAC, Latin America, MEA |
Base Year | 2020 |
Historical Year | 2018 to 2019 (Data from 2010 can be provided as per availability) |
Forecast Year | 2028 |
Number of Pages | 235 |
Number of Tables & Figures | 165 |
Customization Available | Yes, the report can be customized as per your need. |
The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.
The market is segmented by Type (Procedures, Devices), by End Use (Hospital, ASC).
Endometrial Ablation Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.
Key Benefits for Industry Participants & Stakeholders:
Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.
We have studied the Endometrial Ablation Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.
How you may use our products:
Reasons to Purchase the Endometrial Ablation Market Report:
Some other reports from this category!